Aurinia Pharmaceuticals Inc. reports

Company location: Edmonton, Alberta, Canada
Fiscal year end: 31 December

Aurinia Pharmaceuticals Inc. has filed 606 SEC EDGAR filings since 28 Feb 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G
40-F
6-K

SEC filing history

Showing 301-325 of 606 matching filings.

Per page

25

Current page

13

SC 13G/A File 005-88628

SC 13G/A filing

Filing date: 08 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Feb 2021
Reporting date: 29 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Feb 2021
Reporting date: 29 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Jan 2021
Reporting date: 28 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-88628

SC 13D/A

Filing date: 27 Jan 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-88628

SC 13D/A

Filing date: 26 Jan 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36421

8-K

Filing date: 25 Jan 2021
Reporting date: 25 Jan 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

6-K

Filing date: 30 Dec 2020
Reporting date: 30 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 21 Dec 2020
Reporting date: 17 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .